PPWP
RMD icon

Premier Path Wealth Partners’s ResMed RMD Stock Holding History

Premier Path Wealth Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$384K Buy
1,713
+334
+24% +$83.2K 0.05% 312
2025
Q4 		$332K Sell
1,379
-97
-7% -$24.8K 0.04% 312
2025
Q3 		$404K Buy
1,476
+171
+13% +$46.7K 0.05% 289
2025
Q2 		$337K Buy
1,305
+161
+14% +$38.4K 0.05% 308
2025
Q1 		$256K Buy
1,144
+8
+0.7% +$1.87K 0.04% 328
2024
Q4 		$260K Buy
1,136
+28
+3% +$6.74K 0.04% 324
2024
Q3 		$270K Buy
1,108
+32
+3% +$7.15K 0.04% 318
2024
Q2 		$206K Buy
+1,076
New +$218K 0.04% 353

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Premier Path Wealth Partners's RMD Position: Q1 2026 in Review

Premier Path Wealth Partners increased its ResMed (RMD) stake by 24% in Q1 2026, buying an estimated $83.2K and bringing the position to 1,713 shares worth $384K. The position accounts for 0.05% of the portfolio, ranked #312.

Premier Path Wealth Partners first reported a position in RMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $404K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Premier Path Wealth Partners held 1,713 shares of ResMed worth $384K as of Q1 2026.
  • Premier Path Wealth Partners bought 334 ResMed shares in Q1 2026, an estimated $83.2K.
  • ResMed made up 0.05% of Premier Path Wealth Partners's portfolio in Q1 2026, its #312 holding.
  • Premier Path Wealth Partners first reported a position in ResMed in Q2 2024 and has held it in 8 quarters since.
  • Premier Path Wealth Partners's ResMed position peaked at $404K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Premier Path Wealth Partners's 13F filing for Q1 2026, filed 23 Apr 2026.